Castlight Health (CSLT)
(Delayed Data from NYSE)
$2.05 USD
+0.01 (0.49%)
Updated Feb 16, 2022 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Castlight Health, inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 147 | 143 |
Cost Of Goods | NA | NA | NA | 52 | 59 |
Gross Profit | NA | NA | NA | 95 | 84 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 0 | 0 | 157 | 126 |
Income After Depreciation & Amortization | 0 | 0 | 0 | -63 | -41 |
Non-Operating Income | NA | NA | NA | 1 | 1 |
Interest Expense | NA | NA | NA | 0 | 0 |
Pretax Income | NA | NA | NA | -62 | -40 |
Income Taxes | NA | NA | NA | 0 | 0 |
Minority Interest | NA | NA | NA | 0 | 0 |
Investment Gains/Losses | NA | NA | NA | 0 | 0 |
Other Income/Charges | NA | NA | NA | 0 | 0 |
Income From Cont. Operations | NA | NA | NA | -62 | -40 |
Extras & Discontinued Operations | NA | NA | NA | 0 | 0 |
Net Income (GAAP) | NA | NA | NA | -62 | -40 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 0 | 0 | 5 | -20 |
Depreciation & Amortization (Cash Flow) | NA | NA | NA | 68 | 22 |
Income After Depreciation & Amortization | 0 | 0 | 0 | -63 | -41 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 151.48 | 145.17 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | -0.04 | -0.25 |
Diluted Net EPS (GAAP) | NA | NA | NA | -0.41 | -0.28 |
Fiscal Year end for Castlight Health, inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |